In particular, the upregulation of DRs by cisplatin affected TRAIL‐induced apoptosis in many cancer types, such as squamous carcinoma,22 hepatocellular carcinoma23 and colon cancer.24 The mechanism underlying the upregulation of TRAIL receptors is variable. Here, TNFSF10 is linked to cancer.